Hexiris Ophthalmics to Present First-in-Human OBi Glaucoma Data at Five Fall Meetings, Beginning with the Ophthalmology Futures Forum in LondonPhysician-founded company will bring its office-based interventional glaucoma platform to Ophthalmology Futures, ESCRS, Sally Letson, CGS and AAO 2026
WISeKey Shareholders Approve Redomiciliation to the British Virgin Islands at Extraordinary General MeetingWISeKey Shareholders Approve Redomiciliation to the British Virgin Islands at Extraordinary General Meeting
Kaplan Fox & Kilsheimer LLP Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors to a Securities Class Action Deadline on November 3, 2026NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (
NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (the “Class Period”).
Kaplan Fox & Kilsheimer LLP Alerts DICK’s Sporting Goods, Inc. (NYSE: DKS) Investors to a Securities Class Action Deadline on November 3, 2026NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against DICK’s Sporting Goods, Inc. (“Dick’s Sporting Goods” or the “Company”) (
NYSE: DKS) on behalf of investors that purchased or otherwise acquired Dick’s Sporting Goods common stock between September 8, 2025 and August 24, 2026 (the “Class Period”).
Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNXNEW ORLEANS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NasdaqGM: BBNX), if they purchased or otherwise acquired the Company’s common stock between July 30, 2025 and February 24, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.
Simply Good Foods Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against The Simply Good Foods Company - SMPLNEW ORLEANS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Simply Good Foods Company (“Simply Good” or the “Company”) (NasdaqCM: SMPL), if they purchased Simply Good shares between October 24, 2024 and April 8, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
PROCEPT BioRobotics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against PROCEPT BioRobotics Corporation - PRCTNEW ORLEANS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit against PROCEPT BioRobotics Corporation (NasdaqGM: PRCT) (“Procept” or the “Company”), if they purchased the Company’s shares between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.
DICK’S Sporting Goods Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against DICK’S Sporting Goods, Inc. - DKSNEW ORLEANS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against DICK’S Sporting Goods, Inc. (“Dick’s” or the “Company”) (
NYSE: DKS), if they purchased the Company’s common stock between September 8, 2025 and August 24, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Western District of Pennsylvania.
NOTICE TO DISREGARD -- AceUpBOSTON, Sept. 09, 2026 (GLOBE NEWSWIRE) -- We are advised that journalists and other readers should disregard the news release, “AceUp Unveils Ally 3.0: The Only AI Coach Designed to Build Better Leaders and Teams at Work” issued September 9, 2026, over GlobeNewswire.
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMSNEW ORLEANS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hims & Hers Health, Inc. (“Hims” or the “Company”) (
NYSE: HIMS), if they purchased or otherwise acquired the Company’s securities between August 4, 2025 and July 29, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.
Wix.com Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Wix.com Ltd. - WIXNEW ORLEANS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit against Wix.com Ltd. (NasdaqGS: WIX) (“Wix” or the “Company”), if they purchased or otherwise acquired Wix securities between February 19, 2025 and May 12, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of Illinois.
Cogent Communications Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Cogent Communications Holdings, Inc. - CCOINEW ORLEANS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 21, 2026 to file lead plaintiff applications in a securities class action lawsuit against Cogent Communications Holdings, Inc. (NasdaqGS: CCOI) (“Cogent” or the “Company”), if they purchased the Company’s shares between February 29, 2024 and May 1, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Columbia.
Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPRNEW ORLEANS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 28, 2026 to file lead plaintiff applications in a securities class action lawsuit against Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NasdaqGS: CAPR), if they purchased Capricor securities between December 17, 2025 and July 26, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of California.
York Space Systems Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against York Space Systems, Inc. - YSSNEW ORLEANS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 30, 2026 to file lead plaintiff applications in a securities class action lawsuit against York Space Systems, Inc. (“York Space Systems” or the “Company”) (
NYSE: YSS), if they purchased or otherwise acquired (a) York Space Systems common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s January 2026 initial public offering (“IPO” or the “Offering”); and/or (b) securities between January 29, 2026 and May 11, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Colorado.
HDFC Bank Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against HDFC Bank Limited - HDBNEW ORLEANS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against HDFC Bank Limited (“HDFC” or the “Company”) (
NYSE: HDB), if they purchased HDFC securities between July 17, 2023 and May 26, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
EquipmentShare.com Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against EquipmentShare.com Inc. - EQPTNEW ORLEANS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 21, 2026 to file lead plaintiff applications in a securities class action lawsuit against EquipmentShare.com Inc. (NasdaqGS: EQPT) (“EquipmentShare” or the “Company”), if they purchased or otherwise acquired: (a) EquipmentShare.com, Inc. Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s January 2026 initial public offering (the “IPO”); and/or (b) EquipmentShare securities between January 23, 2026 and June 23, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
Avis Budget Group Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Avis Budget Group, Inc. - CARNEW ORLEANS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 29, 2026 to file lead plaintiff applications in a securities class action lawsuit against Avis Budget Group, Inc. (“Avis” or the “Company”) (NasdaqGS: CAR), if they purchased or otherwise acquired Avis securities (including those who bought Avis common stock to cover a short position) between February 20, 2025 and April 21, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Middle District of Florida.
AEVEX Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against AEVEX Corp. - AVEXNEW ORLEANS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 20, 2026 to file lead plaintiff applications in a securities class action lawsuit against AEVEX Corp. (“Aevex” or the “Company”) (
NYSE: AVEX), if they purchased or otherwise acquired Aevex’s publicly traded Class A common stock between April 17, 2026 and June 4, 2026, inclusive (the “Class Period”) and/or pursuant or traceable to the registration statement and prospectus (the “IPO Offering Documents”) issued in connection with Aevex’s April 17, 2026 initial public offering (“IPO”). This action is pending in the United States District Court for the Southern District of California.
Primoris Services Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Primoris Services Corporation - PRIMNEW ORLEANS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 21, 2026 to file lead plaintiff applications in a securities class action lawsuit against Primoris Services Corporation (
NYSE: PRIM) (“Primoris” or the “Company”), if they purchased the Company’s shares between August 5, 2025 and June 22, 2026, both dates inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of Texas.
From China Trials to Abu Dhabi: FREELANDER 8 Builds Momentum for Global Brand LaunchSHANGHAI, Sept. 09, 2026 (GLOBE NEWSWIRE) -- FREELANDER, the British Premium Intelligent All-Terrain Brand, is entering a new chapter with FREELANDER 8. Following extreme high-altitude and safety validation in China, the brand's first strategic model has officially launched in the Chinese market, securing more than 10,000 orders within 48 hours. Now, FREELANDER 8 embarks on its next milestone, with its international variant set to be presented in Abu Dhabi as FREELANDER advances its entry into the Middle East.
SmallRig Launches Modular iPhone 18 Case Ecosystem for Mobile CreatorsA new suite bringing together MagSafe Wallet Stands, Clip-On CPL Filter and Clip-On VND Filter, 2-in-1 Shoulder Straps, 3.5X Telephoto Lenses, and other accessories in versatile, scenario-based kits for travel, street photography, concerts, and everyday content creation.
QUINT Brings Concentrated Exosome Technology Home With Monthly Skin and Scalp ProtocolsThe beauty biotechnology brand combines 25 billion exosomes with precision microneedling in guided, once-monthly systems for face and scalp.
Disc Medicine Presents Initial Results from RESTORE-PV Phase 2 Trial in Patients with Polycythemia Vera (PV) at the 14th Society of Hematologic Oncology (SOHO) Annual MeetingWATERTOWN, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (
NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today presented positive initial results from the RESTORE-PV Phase 2 trial of DISC-3405 in patients with polycythemia vera (PV). The data, presented in a poster session at the 2026 Society of Hematologic Oncology (SOHO) annual meeting in Houston, TX, demonstrated that treatment with DISC-3405 increased hepcidin and lowered serum iron, translating to reduction in phlebotomy, controlled hematocrit, and improved symptom burden in patients with PV. These data will be featured in an oral presentation at the SOHO conference tomorrow, September 10. Disc also presented an encore of the positive results from the Phase 2 RALLY-MF trial of selcodebart (DISC-0974) in patients with anemia of myelofibrosis (MF) and a new systematic literature review characterizing the humanistic burden of anemia associated with MF through patient reported outcomes.
H World Group Limited Announces Pricing of CNY3.35 Billion CNY-denominated Senior BondsSINGAPORE and SHANGHAI, Sept. 10, 2026 (GLOBE NEWSWIRE) -- H World Group Limited (NASDAQ: HTHT and HKEX: 1179) (“H World” or the “Company,” together with its subsidiaries, the “Group”), a key player in the global hotel industry, today announced the pricing of its offering of CNY3.35 billion aggregate principal amount of CNY-denominated senior unsecured bonds (the “Bonds”). The Bonds were offered in offshore transactions outside the United States to non-U.S. persons (the “Bond Offering”) in reliance on Regulation S under the United States Securities Act of 1933, as amended (the “Securities Act”).
GURU Organic Energy Announces Leadership Transition to Support Next Phase of GrowthMONTRÉAL, Sept. 09, 2026 (GLOBE NEWSWIRE) -- GURU Organic Energy Corp. (TSX: GURU) (“GURU” or the “Company”), Canada’s leading organic energy drink brand1, today announced a leadership transition in support of the Company’s next chapter of growth.
GURU Organic Energy Delivers Profitable Quarter With Record Net Revenue of $11.5 MillionU.S. Net Revenue up 59.8%, Net Income of $0.5 Million, and Positive Adjusted EBITDA1 of $0.9 Million
Bitdeer to Present at the 28th Annual H.C. Wainwright & Co. Global Investment ConferenceSINGAPORE, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (
NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company for AI and Bitcoin mining infrastructure, today announced that it will attend the 28th Annual H.C. Wainwright & Co. Global Investment Conference on Monday, September 14, 2026. Michael G. Potter, Chief Financial Officer, will also participate in a panel discussion during the conference.
Fortis Inc. Announces Pricing of Fixed-to-Fixed Rate Junior Subordinated NotesThe Base Shelf Prospectus is accessible, and the Prospectus Supplement and any Amendment to the Documents will be accessible through SEDAR+ within two business days.
ARRAY Opens New Albuquerque Manufacturing Facility with Ribbon Cutting CeremonyThe 216,000 square foot facility represents a significant advancement for domestic manufacturing of American solar technology
Fengate and Mavrek break ground on new 380-unit mixed-use residential development in Chicago’s West LoopChicago, Illinois, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Today, Fengate Asset Management (“Fengate”) and Mavrek Development (“Mavrek”) celebrated the groundbreaking of Julep West Loop, a new 25-story mixed-use residential development in Chicago’s West Loop neighborhood.
Lesaka’s FY2026 Results: Lesaka delivers FY2026 guidance across all metrics, exceeds Adjusted EPS range and achieves GAAP profitabilityJOHANNESBURG, South Africa, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) today released results for the fourth quarter (“Q4 2026”) and full year of fiscal 2026 (“FY2026”).
Defying National Trends: Old Dominion University Marks Historic Enrollment Momentum Driven by Forward-Focused Digital TransformationNorfolk, VA, Sept. 09, 2026 (GLOBE NEWSWIRE) -- In a higher education landscape defined by demographic pressures, intensifying competition and rapidly changing student expectations, Old Dominion University is demonstrating what is possible when an institution chooses to transform around the realities of today’s students. For the first time in five years, Old Dominion University began the fall semester with more than 24,000 students – a significant milestone and one of the clearest signs yet that the University’s Forward-Focused Digital Transformation is producing measurable outcomes in its very first fall.
Lenox Partners with Town & Country Living to Introduce Coordinated Bath CollectionThe new collection extends Lenox’s timeless design and inviting warmth into the bath.
California Waste Solutions Expands Optical Sorting and Adds AI Scanning at Oakland and San Jose FacilitiesSan Jose’s Timothy MRF is increasing Pellenc optical-sorting capacity to improve material recognition, recovery and product purity, while Oakland’s 10th Street MRF is installing EverestLabs AI scanners to measure material flow, missed recovery and line productivity in real time
Discovery Named 2026 TSX30™ Top-Performing CompanyTORONTO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Discovery Mining Ltd. (TSX: DSV, OTCQX: DSVSF) ("Discovery" or the "Company") is pleased to announce that it has been named to the 2026 TSX30™, an annual ranking of the 30 top-performing companies on Toronto Stock Exchange (“TSX”) based on dividend-adjusted share price performance over a three-year period ending June 30, 2026.
Global Indemnity Group, LLC Announces Quarterly DistributionWILMINGTON, Del., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Global Indemnity Group, LLC (Nasdaq: GBLI) ("GBLI") announced that its Board of Directors has approved a distribution payment of $0.35 per common share to be paid on September 30, 2026 to all shareholders of record as of the close of business on September 18, 2026.
Advanced Technology International to Manage Department of the Air Force Tactical Exploitation of National Capabilities (DAF TENCAP) OTASUMMERVILLE, S.C., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Advanced Technology International (ATI) has been awarded an Other Transaction Agreement (OTA) by the United States Air Force to serve as the consortium manager for the Department of the Air Force Tactical Exploitation of National Capabilities (DAF TENCAP) consortium. This consortium is focused on enhancing the warfighters’ lethality, survivability, and combat effectiveness, by delivering cutting edge technology and prototypes in the relevant technology areas of Air, Space, Cyber, and Intelligence.
Pilgrim’s Pride Prices Senior Notes OfferingGREELEY, Colo., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Pilgrim’s Pride Corporation (
NASDAQ: PPC) (the “Company” or “Pilgrim’s Pride”) and Pilgrim’s Europe Finance PLC, a wholly owned subsidiary of the Company incorporated under the laws of England and Wales (together with the Company, the “Issuers”), announced today the pricing of their offering of €500 million aggregate principal amount of 4.750% senior notes due 2034 (the “Notes”).The sale of the Notes is expected to close on September 23, 2026, subject to customary closing conditions.
Cal-Maine Foods Schedules First Quarter Fiscal 2027 Earnings Release, Conference Call and WebcastRIDGELAND, Miss., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (Nasdaq: CALM) (“Cal-Maine Foods,” “we,” “us,” “our” or the “company”), the largest egg company in the United States and a leading player in the egg-based food industry, today announced it will report results for its fiscal 2027 first quarter at approximately 6:00 a.m. ET on Wednesday, September 30, 2026. The earnings release will be available on the Cal-Maine Foods website at https://investors.calmainefoods.com/press-releases.
CooperCompanies Announces Third Quarter 2026 ResultsSAN RAMON, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2026.
Crescent Biopharma Announces Grants of Inducement AwardsWALTHAM, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that the independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 58,650 shares of the Company’s ordinary shares to two non-executive employees as equity inducement awards under the Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan, as amended (the “Inducement Plan”). The options were approved on September 8, 2026 and were material to each employee's acceptance of employment with Crescent, in accordance with Nasdaq Listing Rule 5635(c)(4).
NANOBIOTIX to Participate in the H.C. Wainwright 28th Annual Global Investment ConferencePARIS and CAMBRIDGE, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer and other major diseases, today announced that Company management will participate in a fireside chat at the following investment conference:
Royalty Pharma to present at upcoming investor conferencesNEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of September:
XPO Schedules Third Quarter 2026 Earnings Conference Call for Thursday, October 29, 2026GREENWICH, Conn., Sept. 09, 2026 (GLOBE NEWSWIRE) -- XPO (
NYSE: XPO) will hold its third quarter conference call and webcast on Thursday, October 29, at 8:30 a.m. Eastern Time. The company's results will be released earlier that morning and made available on www.xpo.com.
MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment ConferenceROCKVILLE, MD, Sept. 09, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that Eric Risser, President and CEO of MacroGenics, will present at the H.C. Wainwright 28th Annual Global Investment Conference on Wednesday, September 16, 2026, at 9:30 a.m. ET.
Century Therapeutics Appoints Joseph Truitt to Board of DirectorsPHILADELPHIA, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases, including type 1 diabetes (T1D), and cancer, today announced the appointment of Joseph Truitt to its Board of Directors.
ThredUp to Participate in Goldman Sachs and Wells Fargo ConferencesOAKLAND, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- ThredUp Inc. (Nasdaq: TDUP, LTSE: TDUP), one of the largest online resale platforms for apparel, shoes, and accessories, announced today that CEO and co-founder James Reinhart and CFO Sean Sobers will participate in the following investor conferences:
Huachen AI Parking Management Technology Holding Co., Ltd. Announces Strategic Cooperation with Beyinda Limited to Expand Precision Metal Components Market in ChinaFramework agreement combines Huachen’s market development capabilities with Beyinda’s manufacturing expertise across new energy vehicle, charging infrastructure, energy storage and other industrial applications
Wealthfront Reports Fiscal Second Quarter 2027 ResultsTotal Platform Assets up 12% year-over-year to $99.0 billion at the end of the quarterFunded clients up 14% year-over-year to 1.5 million at the end of the quarterSurpassed $100 billion in Total Platform Assets as of the end of August
Genelux Announces Publication of a Deep and Durable Response in a Platinum-relapsed Small Cell Lung Cancer Patient Following Systemically Delivered Olvi-Vec-Primed Immunochemotherapy-- A platinum-relapsed SCLC patient achieved 16.7 months progression-free survival following Olvi-Vec and platinum rechallenge, exceeding the PFS achieved following platinum-based first-line therapy --
Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare ConferenceMENLO PARK, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis and hidradenitis suppurativa, today announced its attendance at the 2026 Morgan Stanley Global Healthcare Conference, taking place in New York, NY from September 14-16, 2026.About Oruka TherapeuticsOruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka’s mission is to offer patients suffering from inflammatory diseases like plaque psoriasis and hidradenitis suppurativa the greatest possible freedom from their condition by achieving high rates of disease clearance with dosing as infrequently as once or twice a year. For more information, visit www.orukatx.com and follow Oruka on LinkedIn.
Lakeland Fire + Safety Reports Fiscal Second Quarter 2027 ResultsQ2 FY27 Net Sales of $50.1 Million; Fire Increased 12% Sequentially
Zoher F. Kapasi, PhD, PT, Named Provost of Thomas Jefferson UniversityPHILADELPHIA, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Thomas Jefferson University has announced the appointment of Zoher F. Kapasi, PhD, PT, as its next Provost effective Nov. 1, 2026.
Hong Kong Tourism Board Launches “Only in Hong Kong,” a New Global Campaign Celebrating a City Travelers Don’t Just See, But FeelSpotlighting the sights, sounds, flavors and unmistakable character of Hong Kong through a bold new visual identity and creative voice
Bridging the Gap Between Military Experience and Civilian Careers: 5 Tips for VeteransNEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- (Feature Impact) Every year, approximately 200,000 service men and women transition from military life to corporate America. Finding the right civilian career is a transition, but it’s an opportunity to leverage military leadership and mission-driven talent.
NEW IPR STUDY WITH THE GROSSMAN GROUP FINDS RISING BURNOUT AMONG HIGHLY ENGAGED COMMUNICATORSNew York, Sept. 09, 2026 (GLOBE NEWSWIRE) -- NEW IPR STUDY WITH THE GROSSMAN GROUP FINDS RISING BURNOUT AMONG HIGHLY ENGAGED COMMUNICATORS
Lexitas Leaders to Lead AI Roundtable at Women, Influence & Power in Law Conference 2026Brandy Patrick and Brennan Tucker will share strategies for driving AI adoption and operational success across legal organizations
IRES MLS Names Julie Dahl as Next CEOLong-time IRES staff veteran to lead Northern Colorado MLS into its next chapter, bringing industry knowledge, continuity and fresh perspectives
FlyEpic Is Making the West Smaller, One Flight at a TimeFrom business routes to weekends away, FlyEpic is changing regional travel with a smarter approach to private aviation
Dark Horse Consulting Group Marks the Opening of Its Shanghai Office with Ribbon Cutting CeremonyWALNUT CREEK, Calif. and SHANGHAI, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Dark Horse Consulting Group (DHCG) marked the opening of its Shanghai office with a ribbon cutting ceremony celebrating Dark Horse Consulting China. The event brought together DHCG leadership, “Shanghai Center of Biomedicine Development”, “China leading CDMO and CRO companies”, and invited guests from across the region's life sciences community. Anthony Davies, Ph.D., Founder and CEO, led the ceremony, joined by John Ng, MBA, General Manager, DHC Asia Pacific, and Kang Liu, Ph.D., Senior Director, Head of China. The ribbon cutting ceremony is jointly performed by Mr. Zhang Hua, Deputy Director at Shanghai Center of Biomedicine Development, Anthony Davies, Founder and CEO at DHCG and John Ng, GM APAC at DHCG.
LG Electronics USA Introduces LG MAGNIT Gen 2 Micro LED DisplayLaunching in U.S. at Starpower in Dallas, Giant New Display Combines LG Micro LED Technology with NovaStar’s LED Control System
Sobi Receives US FDA Fast Track Designation for pacritinib in VEXAS SyndromeWALTHAM, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi®), today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation to pacritinib for the treatment of VEXAS syndrome. Pacritinib is a dual IRAK1/JAK2 inhibitor currently in Phase ll development for VEXAS syndrome.
Cozy, Bold and Everything In-Between: The Human Bean's Fall Drinks Arrive September 9Medford, OR, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Kicking off on September 9th, The Human Bean is debuting a new lineup of fall drinks for coffee-lovers, chai-goers, and Bright® Energy-sippers. Each beverage captures the season's energy in a way that feels fresh, unexpected, and genuinely worth the wait all year long. Fall is now!
Grupo Bimbo Reports 73% Growth in Regenerative Agriculture, Reaching More Than 500,000 Acres HectaresMEXICO CITY, Sept. 09, 2026 (GLOBE NEWSWIRE) -- In recognition of World Agriculture Day, Grupo Bimbo reaffirms its commitment to an agricultural model that restores soil health and protects ecosystems. By the end of 2025, the world’s largest baking company surpassed 500,000 hectares cultivated under regenerative agriculture practices, representing 73% growth compared to the more than 290,000 hectares reported in 2024.
IROQUOIS VALLEY REBRANDS AS AMBER FARMLAND INVESTMENTS MARKING ITS NEXT CHAPTER IN BUILDING THE ORGANIC FUTURENew Identity Reflects Commitment to Expand USDA-Certified Organic Farmland Across the U.S. Through Farmer Partnerships, Real-Asset Investing and Long-Term Land Stewardship
Campaign Monitor Launches Marketing Studio, Bringing Campaign Creation, Design, Translation, and Social Publishing Into a Unified, Smart WorkflowNASHVILLE, Tenn., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Marigold, a global marketing intelligence company focused on helping growing businesses build stronger customer relationships, today announced the launch of Marketing Studio, a new campaign creation experience inside Campaign Monitor. Marketing Studio brings five smart capabilities together in a single workflow: Email Workspace, Creative Lab, Translation, Brand Hub, and Social Suite, giving small marketing teams and solo business owners everything they need to build, brand, translate, and publish a campaign without leaving the platform.
Association of Clinical Research Professionals Opens Applications for 2026–27 Scholarships and Grants ProgramMade possible through support from Peter the Protocol Reader by Care Access, the program expands opportunities for education, certification, and professional growth in clinical research
Peapack Private Expands Specialty Lending Capabilities with Launch of Yacht Financing BusinessBEDMINSTER, N.J., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Peapack-Gladstone Financial Corporation (NASDAQ Global Select Market: PGC) and Peapack Private announced today its entrance into the yacht financing business, further expanding the Bank’s suite of customized lending solutions for high-net-worth individuals, families and their advisors. As part of the launch, Peapack Private has hired industry veterans, Jim Velez, and Derick Buffum, to lead the new Yacht Financing team.
